Cyclin A-type Activators would represent a class of molecules that specifically increase the activity of cyclin A, a member of the cyclin family of proteins. Cyclins are regulatory proteins that control the progression of cells through the cell cycle by activating cyclin-dependent kinases (CDKs). Cyclin A exists in two forms in vertebrates: cyclin A1, which is expressed during meiosis, and cyclin A2, which is expressed during mitosis. The activators of cyclin A-type would likely function by promoting the association between cyclin A and its partner CDKs, stabilizing the complex, or enhancing its kinase activity, which is essential for the transition from the S phase to the M phase of the cell cycle. These activators could bind to cyclin A and induce conformational changes that favor its activation or could interact with the regulatory pathways that control the synthesis or degradation of cyclin A, thus affecting its cellular levels and activity.
To study cyclin A-type activators, a multidisciplinary approach involving biochemistry, cell biology, and molecular biology would be essential. Biochemical methods could include in vitro kinase assays to measure CDK activity in the presence of cyclin A and potential activators, helping to quantify the effect of these molecules on the enzymatic function of the cyclin A-CDK complex. Additionally, protein interaction assays, such as co-immunoprecipitation, could be used to assess the impact of activators on the formation and stability of the cyclin A-CDK complex. Molecular investigations might involve the use of reporter assays to determine how cyclin A-type activators influence the transcription of genes downstream of the cyclin A pathway. Furthermore, the use of synchronized cell populations would allow for the precise analysis of the effects of these activators on cell cycle progression, particularly the S to M phase transition. Through these investigative techniques, a comprehensive understanding of the mechanisms by which cyclin A-type activators modulate cyclin A function could be achieved, shedding light on the intricate control of cell cycle dynamics.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
This compound induces DNA damage, which can activate cell cycle checkpoints and potentially increase cyclin A expression as part of the DNA damage response. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Another DNA-damaging agent that can lead to activation of cell cycle checkpoints and might increase cyclin A expression as a cellular response. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
A nucleotide analog that disrupts DNA synthesis, potentially upregulating cyclin A expression as cells attempt to overcome the blockage of DNA replication. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
An inhibitor of dihydrofolate reductase that results in DNA synthesis blockade, which might trigger an upregulation of cyclin A to compensate. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $76.00 $255.00 | 18 | |
A ribonucleotide reductase inhibitor that leads to a depletion of deoxyribonucleotide pools, potentially affecting cyclin A expression. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
Causes DNA crosslinks and damage, leading to cell cycle arrest, which may subsequently induce cyclin A expression as part of the cellular response. | ||||||
Bleomycin | 11056-06-7 | sc-507293 | 5 mg | $270.00 | 5 | |
Induces DNA breaks, which activates cell cycle checkpoints and could potentially influence cyclin A expression. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $100.00 $230.00 $450.00 $1715.00 $2900.00 | 4 | |
A microtubule-disrupting agent that arrests cells at the G2/M phase, potentially affecting cyclin A expression as cells respond to mitotic stress. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
Disrupts microtubule polymerization, causing cell cycle arrest, which may lead to changes in cyclin A expression levels. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Affects cell differentiation processes and may upregulate cyclin A expression as part of the regulation of cell proliferation. | ||||||